Vinod Elizabeth, Boopalan P R J V C, Sathishkumar Solomon
1 Department of Physiology, Christian Medical College, Vellore, India.
2 Department of Orthopaedics, Christian Medical College/Center for Stem Cell Research, Vellore, India.
Cartilage. 2018 Apr;9(2):171-182. doi: 10.1177/1947603517736108. Epub 2017 Oct 19.
Introduction Articular cartilage is made up of hyaline tissue embodying chondrocytes, which arise from mesenchymal stromal cells (MSCs) and specialized extracellular matrix. Despite possessing resident progenitors in and around the joint primed for chondrogenesis, cartilage has limited intrinsic capacity of repair and cell turnover. Advances in isolation, culture, and characterization of these progenitors have raised the possibility for their use in cell-based cartilage repair. Chondroprogenitors (CPCs) have been classified as MSCs and have been postulated to play a vital role in injury response and are identified by their colony forming ability, proliferative potential, telomere dynamics, multipotency, and expression of stem cell markers. The combined presence of CPCs and chondrocytes within the same tissue compartments and the ability of chondrocytes to dedifferentiate and acquire stemness during culture expansion has obscured our ability to define and provide clear-cut differences between these 2 cell populations. Objective This review aims to evaluate and summarize the available literature on CPCs in terms of their origin, growth kinetics, molecular characteristics, and differential and therapeutic potential with emphasis on their difference from daughter chondrocytes. Design For this systematic review, a comprehensive electronic search was performed on PubMed and Google Scholar using relevant terms such as chondrocytes, chondroprogenitors, and surface marker expression. Results and Conclusion Our comparative analysis shows that there is an ill-defined distinction between CPCs and chondrocytes with respect to their cell surface expression (MSC markers and CPC-specific markers) and differentiation potential. Accumulating evidence indicates that the 2 subpopulations may be distinguished based on their growth kinetics and chondrogenic marker.
引言 关节软骨由包含软骨细胞的透明组织构成,软骨细胞起源于间充质基质细胞(MSC)并具有特殊的细胞外基质。尽管关节内及周围存在准备进行软骨形成的固有祖细胞,但软骨的自我修复和细胞更新能力有限。这些祖细胞在分离、培养和鉴定方面的进展增加了其用于基于细胞的软骨修复的可能性。软骨祖细胞(CPC)已被归类为MSC,并被认为在损伤反应中起重要作用,可通过其集落形成能力、增殖潜力、端粒动态、多能性和干细胞标志物表达来识别。同一组织区域内CPC和软骨细胞的共同存在,以及软骨细胞在培养扩增过程中去分化并获得干性 的能力,模糊了我们定义和明确这两种细胞群体之间差异的能力。目的 本综述旨在评估和总结关于CPC的现有文献,内容涉及其起源、生长动力学、分子特征、差异和治疗潜力,重点是其与子代软骨细胞的差异。设计 对于本系统综述,使用软骨细胞、软骨祖细胞和表面标志物表达等相关术语在PubMed和谷歌学术上进行了全面的电子检索。结果与结论 我们的比较分析表明,CPC和软骨细胞在细胞表面表达(MSC标志物和CPC特异性标志物)和分化潜力方面的区别尚不明确。越来越多的证据表明,这两个亚群可根据其生长动力学和成软骨标志物来区分。